Kaiser Permanente
Seattle, Washington, 98101, United States
NCT Number: NCT05747443
Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
This study is active but is not currently recruiting participants.
Notify Me50 year–78 year
All sexes
Interventional
Not applicable
Seattle, Washington, 98101, United States
Screening for lung cancer has the potential for a profound public health benefit.
Successful population-based screening requires continuous monitoring to adherence repeat screening in high risk adults to achieve similar results. Repeat annual screening is necessary for early detection of lung cancer. Baseline or first LDCT scans detect prevalent lung cancer, when subsequent screening detects new nodules. However, adherence to screening is low, ranging at 28-38% from centers nationally.
The investigators developed two novel, patient-centered interventions to address patient education and offering reminders for on-time screening. To address these goals, the specific aims are to: 1) Compare effectiveness of two multilevel interventions relative to usual care in improving (a) rates of adherence to lung cancer screening, (b) patient-centered outcomes; and (c) clinic outcomes; and 2) Determine the patient-, clinician-, and system-level factors that influence changes in adherence to inform lung cancer screening programs.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stepped Reminders, which directly reminds providers to order the next LDCT scan and then reminds patients they are due and prompts them to schedule LDCT with Radiology.
The Patient Voices Video is an educational video about lung cancer screening.
Time frame: 9-15 months after index LDCT
Electronic health records will be searched for screening low dose CT (LDCT).
Time frame: 8 weeks after index LDCT
Knowledge of lung cancer screening eligibility, time to return and cost on patient reported outcomes survey.
Time frame: 8 weeks after index LDCT
The Lung Cancer Screening Health Belief Scale measures self-efficacy for lung cancer screening. The self-efficacy for lung cancer screening scale ranges from 9-36, with higher scores indicating lower self-efficacy.
Kaiser Permanente
Other
Acronym: Larch
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06538636
Lung Cancer, Lung Cancer Screening
Bedford, Massachusetts, United States
View Trial DetailsNCT07478757
Lung Cancer, Lung Cancer Screening
Hong Kong
View Trial DetailsNCT05645731
Behavior, Health Behavior
Montreal, Quebec, Canada
View Trial DetailsNCT07008664
Healthy Volunteers (HV), Lung Cancer
Glen Burnie, Maryland, United States
View Trial Details